Tirzepatide produces faster initial weight loss due to dual GIP/GLP-1 receptor agonism, with the SURMOUNT-1 trial showing 1520.9% reduction depending on dose at 72 weeks
Borner T, Geisler CE, Fortin SM, Cosgrove R, Alsina-Fernandez J, Dogra M, Doebley S, Sanchez-Navarro MJ, Leon RM, Gaisinsky J, et al
You can also look into coupons from the manufacturers of the drugs, as well as less expensive versions of certain well-known drugs
Heres a detailed look at what you can expect: Personal Dietitian Meetings: For patients receiving insurance-covered care, you'll have a meeting with your personal dietitian on a monthly basis
Wang et al., 2015